BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:33 PM
 | 
Jun 30, 2009
 |  BC Extra  |  Company News

NICE rebuffs Yondelis

The U.K.'s NICE issued a preliminary appraisal recommending against the use of Yondelis trabectedin from PharmaMar S.A. (Madrid, Spain) to treat advanced soft tissue sarcoma. The cytotoxic alkaloid that binds the minor...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >